Welcome to the investors section of Adocia  

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.


Latest Press Releases
2017/07/19Adocia presents first half 2017 financial results
Read more
2017/07/11Number of shares and voting rights of ADOCIA as of June 30, 2017
Read more

All Press releases

Next events

11-15 September 2017 53rd EASD Annual Meeting 2017, Lisbon, Portugal - 53rd EASD Annual Meeting of the European Association for the Study of Diabetes
See event

All events